1 / 19

Chronic Kidney Disease

Chronic Kidney Disease. Ulysses Rosas May 8 th , 2012. Outline. Define Chronic Kidney Disease. Briefly discuss it’s pathophysiology, epidemiology, and risk factors. Discuss the role of genetics in Chronic Kidney Disease.

mora
Download Presentation

Chronic Kidney Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chronic Kidney Disease Ulysses Rosas May 8th, 2012

  2. Outline • Define Chronic Kidney Disease. • Briefly discuss it’s pathophysiology, epidemiology, and risk factors. • Discuss the role of genetics in Chronic Kidney Disease. • Look at relationship between the UMOD gene and MMP20 gene with chronic kidney disease. • Assess how these genes affect the risk and diagnosis of Chronic Kidney Disease. • What knowledge would a physician and patient want to know to understand how their genotype affects their risk for developing chronic kidney disease.

  3. Que es Eso? Chronic Kidney Disease is defined as a slow lose of renal function over time. This leads to a decreased ability to remove waste products from the body and perform homeostatic functions.

  4. Clinical Definition • GFR of less than 60 ml/minute per 1.73m2 per body surface area (normal is 125ml/min) . • GFR Calculator: http://www.kidney.org/professionals/kdoqi/gfr_calculator.cfm • Presence of kidney damage, regardless of the cause, for three or more months

  5. Epidemiology • CKD affects about 26 million people in the US • Approximately 19 million adults are in the early stages of the disease • On the rise do to increasing prevalence of diabetes and hypertension • Total cost of ESRD in US was approximately $40 billion in 2008

  6. Pathophysiology • Repeated injury to kidney

  7. Symptoms • Hematuria • Flank pain • Edema • Hypertension • Signs of uremia • Lethargy and fatigue • Loss of appetite • If asymptomatic may have elevated serum creatinine concentration or an abnormal urinalysis

  8. Risk Factors • Age of more than 60 years • Hypertension and Diabetes • Responsible for 2/3 of cases • Cardiovascular disease • Family history of the disease. • Race and ethnicity • Highest incidence is for African Americans • Hispanics have higher incidence rates of ESRD than non-Hispanics.

  9. Convergence of Genetic Factors • Genes for heart and vascular disease • Genes that maintain ionic balance • Genes for glomerulonephritis • Genes for diabetes • Genes that may be involved in inherited renal diseases

  10. Genetics of CKD • Markers of kidney function found to be 27-33% heritable. • Serum creatinine, GFR, albumin, proteinuria, BUN • Many genes associated with chronic kidney disease: • APOL1 in African Americans • UMOD • SHROOM3 • GATM-SPATA5L1 • MMP20 • MPPED2, DDX1, CDK12, CASP9, and INO80 • LASS2, GCKR, ALMS1, TFDP2, DAB2, SLC34A1, VEGFA, PRKAG2, PIP5K1B, ATXN2, DACH1, UBE2Q2, and SLC7A9N

  11. Genes Looked At • UMOD gene • Encodes urodoulin protein. • Function unknown but thought to be involved immunologically. • UMOD is transcribed exclusively in renal tubular cells of the thick ascending limb of the loop of Henle. • MMP20 • Encodes a member of the matrix metalloproteinase family, which are involved in the breakdown of extracellular matrix in normal physiological processes. • MMP20 degrades amelogenin, found mostly in tooth enamel. • MMP20 recently implicated to be associated with kidney disease aging.

  12. UMOD Gene

  13. MMP20 Gene

  14. Risk Translated • Average population risk for chronic kidney disease is 3.4% • In people with rs4293393-T, serum creatinine increases faster with age (especially over the age of 50), and with comorbid conditions such as hypertension and diabetes. • In people with rs13333226-G, is associated with a slightly lower risk of hypertension and a 7.7% reduction per allele for risk of CV events. • In people with rs12917707-T, we see a 20% decreased risk of CKD • In people with rs1711437-A, their creatinine clearance is approximately that of someone who is 4–5 years younger.

  15. What Should Patients and Doctors Know • In general CKD is characterized by a gradual loss of the kidney’s filtration capacity. • Markers Don’t tell everything • Genetic variants found so far only account for 1.4% of variance seen in eGFR, and at most the relative risk for CKD is modified by 20% per loci.

  16. What Should Patients and Doctors Know • Genetic Risk does not translate into clinical risk • Complex interaction with environmental factors • Would need to calculate a likelihood ratio in conjunction with a probability of disease prevalence to gain a better estimate of clinical risk.

  17. What Should Patients and Doctors Know • Prevention • Keep diabetes and blood pressure controlled • If at risk perform screening tests • Reduce exposure to nephrotoxic drugs • Eat right and exercise • Know your family history • If you have a positive family history ask doctor to perform common screening tests for kidney function.

  18. Sources • Wheeler et al 2009. Sequential Use of Transcriptional Profiling, Expression Quantitative Trait Mapping, and Gene Association ImplicatesMMP20 in Human Kidney Aging. • Padmanabhan S et al. (2010) . “Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.”PLoS Genet. 6(10):e1001177. • Gudbjartsson DF et al. (2010) . “Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.” PLoS Genet. 6(7):e1001039. • Köttgen A et al. (2009) . “Multiple loci associated with indices of renal function and chronic kidney disease.” Nat. Genet. 41(6):712-7.

More Related